AAN

Shedding light on CIDP

1920 1080 Carlotta Foletti, PhD

While it is the most common chronic autoimmune neuropathy, chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, acquired peripheral neuropathy characterised by proximal upper and lower limb weakness. CIDP remains…

read more
lab

Establishing sNfL as an MS Biomarker

3300 2200 Carlotta Foletti, PhD

At the ECTRIMS annual congress in October 2018, there was a lot of talk on serum neurofilament light (sNfL) becoming the first blood biomarker predicting neuronal damage caused by neurological…

read more
news

News from the ocrelizumab front

3300 2200 Carlotta Foletti, PhD

In our ongoing coverage of the AAN Annual Meeting in Philadelphia, we are focusing on select posters reporting on studies of ocrelizumab, an intravenous humanised monoclonal antibody that selectively targets…

read more
Doctor

Latest advances in migraine therapy

3682 2200 Carlotta Foletti, PhD

Migraines are the most common type of primary headache disorders, and triptans – serotonin 5-HT1B/1D receptor agonists originally developed as cranial vasoconstrictors – are the backbone of current acute attack…

read more

Preventing migraines through diet

1920 1080 Carlotta Foletti, PhD

As part of our coverage on the updates in migraine research at the 2019 AAN Annual Meeting, we attended Dr Belinda Savage-Edwards’ presentation – in collaboration with chef Tess Connors…

read more

An update on chronic migraine diagnosis

3300 2200 Carlotta Foletti, PhD

Headache disorders are among the leading causes of years lived with disability, in both men and women.1 Chronic migraines, in particular, are typically estimated to have a global prevalence of…

read more
Brainwork is supported by unrestricted grants from: